Computational analysis reveals biomarkers for esophageal carcinoma, suggesting potential diagnostic value.
Enhancer hypomethylation is a hallmark of ESCA, nominating LINC02547 and PYGL as biomarker candidates with diagnostic/prognostic promise. Limitations include retrospective design and need for experimental validation.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: